Suppr超能文献

根治性手术:胆管癌的血管和胰腺切除术。

Radical surgery: vascular and pancreatic resection for cholangiocarcinoma.

机构信息

Aichi Cancer Center, Nagoya, Japan.

出版信息

HPB (Oxford). 2008;10(3):183-5. doi: 10.1080/13651820801992682.

Abstract

Recent progress in vascular surgical techniques has made it possible to combine liver and portal vein and/or hepatic artery (HA) or retrohepatic inferior vena cava (IVC) resection and reconstruction in cases of locally advanced cholangiocarcinoma. Reports of the success of this difficult surgery have been published. Aggressive Japanese surgeons have applied hepatopancreatoduodenectomy (HPD) not just in cases of advanced gallbladder cancer, but also in locally advanced cholangiocarcinoma with or without superficial spread. The above extended surgeries were associated with high postoperative morbidity and mortality, but recent progress in perioperative management and surgical techniques has improved the outcome of these types of surgery. Combined portal vein and liver resection provides R0 resection and contributes to longer survival in resected patients with locally advanced cholangiocarcinoma than in unresected patients. Portal vein invasion is a strong prognostic factor of cholangiocarcinoma and the actual number of 5-year survivors is limited. The number of clinical cases of liver resection combined with IVC or HA resection and reconstruction is still limited, and therefore the long-term survival benefit from these procedures has not been clarified. HPD carried high morbidity and mortality rates in the 1990s, but the outcome has been improving and an increasing number of 5-year survivors has been reported. Although the clinical value of the above extended surgeries has not been evaluated prospectively, with the increasing number of retrospective studies it has been concluded that combined liver and portal vein and/or HA or IVC resection or HPD could be indicated for selected patients with locally advanced cholangiocarcinoma.

摘要

近年来,血管外科技术的进步使得在局部晚期胆管癌患者中联合进行肝和门静脉及/或肝动脉(HA)或肝后下腔静脉(IVC)切除和重建成为可能。已经发表了成功实施这一复杂手术的报告。激进的日本外科医生不仅将肝胰十二指肠切除术(HPD)应用于晚期胆囊癌,也应用于局部晚期胆管癌伴或不伴浅表扩散。上述扩大手术与较高的术后发病率和死亡率相关,但围手术期管理和手术技术的最新进展改善了这些类型手术的结果。联合门静脉和肝切除术提供了 R0 切除,与未切除的局部晚期胆管癌患者相比,可延长切除患者的生存时间。门静脉侵犯是胆管癌的一个强烈预后因素,实际 5 年生存率有限。肝切除术联合 IVC 或 HA 切除和重建的临床病例数量仍然有限,因此这些手术的长期生存获益尚未明确。HPD 在 20 世纪 90 年代具有较高的发病率和死亡率,但手术结果一直在改善,越来越多的患者报告 5 年生存。虽然尚未前瞻性评估上述扩大手术的临床价值,但随着越来越多的回顾性研究,已经得出结论,对于局部晚期胆管癌的某些选定患者,联合肝和门静脉及/或 HA 或 IVC 切除或 HPD 可能是适应证。

相似文献

1
Radical surgery: vascular and pancreatic resection for cholangiocarcinoma.
HPB (Oxford). 2008;10(3):183-5. doi: 10.1080/13651820801992682.
2
Review of hepatopancreatoduodenectomy for biliary cancer: an extended radical approach of Japanese origin.
J Hepatobiliary Pancreat Sci. 2014 Aug;21(8):550-5. doi: 10.1002/jhbp.80. Epub 2014 Jan 27.
5
Right trisectionectomy with principle en bloc portal vein resection for right-sided hilar cholangiocarcinoma: no-touch technique.
Ann Surg Oncol. 2012 Apr;19(4):1324-5. doi: 10.1245/s10434-011-2072-x. Epub 2011 Oct 15.
6
[Intrahepatic cholangiocarcinoma followed by vascular invasion: is surgical treatment justified?].
Khirurgiia (Mosk). 2018(6):49-57. doi: 10.17116/hirurgia2018649-57.
9
Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience.
J Hepatobiliary Pancreat Sci. 2010 Jul;17(4):476-89. doi: 10.1007/s00534-009-0204-5. Epub 2009 Oct 23.
10
Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not?
Surgery. 2007 May;141(5):581-8. doi: 10.1016/j.surg.2006.09.016. Epub 2007 Mar 23.

引用本文的文献

2
Evolving role of vascular resection and reconstruction in hepatic surgery for malignancy.
Hepat Oncol. 2014 Jan;1(1):53-65. doi: 10.2217/hep.13.5. Epub 2013 Dec 20.
3
Extra-Hepatic Bile Duct Resection: an Insight in the Management of Gallbladder Cancer.
J Gastrointest Cancer. 2015 Sep;46(3):291-6. doi: 10.1007/s12029-015-9737-9.

本文引用的文献

2
Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not?
Surgery. 2007 May;141(5):581-8. doi: 10.1016/j.surg.2006.09.016. Epub 2007 Mar 23.
3
Hepatopancreatoduodenectomy: its suitability for bile duct cancer versus gallbladder cancer.
J Hepatobiliary Pancreat Surg. 2007;14(2):142-8. doi: 10.1007/s00534-006-1108-2. Epub 2007 Mar 27.
4
Is major hepatectomy with pancreatoduodenectomy justified for advanced biliary malignancy?
J Hepatobiliary Pancreat Surg. 2007;14(2):136-41. doi: 10.1007/s00534-006-1107-3. Epub 2007 Mar 27.
5
Portal vein resection for hilar cholangiocarcinoma.
Am Surg. 2006 Jul;72(7):599-604; discussion 604-5.
6
Combined liver resection and reconstruction of the supra-renal vena cava: the Paul Brousse experience.
Ann Surg. 2006 Jul;244(1):80-8. doi: 10.1097/01.sla.0000218092.83675.bc.
7
Clinical significance of reconstruction of the right hepatic artery for biliary malignancy.
Langenbecks Arch Surg. 2006 Jun;391(3):203-8. doi: 10.1007/s00423-006-0026-8. Epub 2006 Mar 9.
8
Surgical management of hilar cholangiocarcinoma.
Ann Surg. 2005 May;241(5):693-9; discussion 699-702. doi: 10.1097/01.sla.0000160701.38945.82.
10
Combined resection of the liver and inferior vena cava for hepatic malignancy.
Ann Surg. 2004 May;239(5):712-9; discussion 719-21. doi: 10.1097/01.sla.0000124387.87757.eb.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验